Entering text into the input field will update the search result below

Merrimack finance chief bids adieu

  • Merrimack Pharmaceuticals (NASDAQ:MACK) CFO and Head of Corporate Development Dr. Yasir Al-Wakeel will resign effective June 9 to pursue other interests. A search has been initiated for a successor.

Recommended For You

About MACK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MACK--
Merrimack Pharmaceuticals, Inc.